Real Chemistry and Corval Partner to Elevate Biopharma Commercialization

Oct 03, 2024

Leveraging Real Chemistry’s differentiated deep biopharma expertise and Corval’s cutting-edge commercialization planning platform, the collaboration aims to accelerate clinic-to-market readiness for groundbreaking therapies

Posted by Corval

Press Release: NEW YORK, Oct. 2, 2024 – Real Chemistry, a leader in AI-driven insights and marketing communications for the healthcare sector, today announced a partnership with Corval to introduce to Real Chemistry customers a new commercialization planning and launch platform designed to enhance efficiency and strategic alignment for biopharma companies. 

The Corval® platform’s ability to create and manage flexible, end-to-end multi-year commercialization roadmaps, budgets and resource plans, together with Real Chemistry’s sophisticated expertise, integrated services and unparalleled data insights, provide a significant competitive advantage, enabling clients to respond more dynamically to changes in their data, the market and their strategy.

Read more…

See all Member News